NEW YORK (GenomeWeb News) – The National Cancer Institute seeks to fund researchers who will conduct innovative work aimed at developing or improving models for assessing cancer risk and prognosis.

These research programs could include studies to identify or validate protein biomarkers or genetic variants that could be used to develop the prediction models, according to a recently published program announcement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.